This inventor holds 1 USPTO granted patent. Top assignee: Leuven Research & Development Vzw. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: The Innovations of Dingeman C Rijken
Introduction
Dingeman C Rijken is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombolytic agents. His work has the potential to impact the treatment of thrombosis disorders, showcasing the importance of innovation in medical science.
Latest Patents
Dingeman C Rijken holds a patent for a plasminogen activator and pharmaceutical composition having thrombolytic properties. This new plasminogen activator, which is similar to the one found in blood, can be isolated in substantial amounts from the culture fluid of human melanoma cells. The strong thrombolytic effect of this activator makes it a promising candidate for therapeutic applications in treating thrombosis disorders. He has 1 patent to his name.
Career Highlights
Rijken is associated with Leuven Research & Development Vzw, where he continues to explore innovative solutions in the pharmaceutical industry. His research focuses on enhancing the efficacy of thrombolytic treatments, which are crucial for patients suffering from blood clots.
Collaborations
Some of his notable coworkers include Desire J Collen and Osamu Matsuo. Their collaborative efforts contribute to advancing research in the field of thrombolytic agents.
Conclusion
Dingeman C Rijken's work exemplifies the vital role of inventors in the advancement of medical treatments. His innovations in plasminogen activators hold promise for improving therapeutic options for thrombosis disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile